Injective gains momentum as 21Shares seeks SEC approval for INJ ETF
21Shares on Monday filed with the U.S. SEC for an Injective ETF, the second INJ exchange-traded fund in development after Canary Capital's July application.
Stay ahead with real-time cryptocurrency news, market insights and expert analysis from trusted sources.
Market sentiment indicator (24h)
Loading market data...
Market sentiment indicator (24h)
Loading market data...